Rong Wang | Oncology | Best Researcher Award

Dr. Rong Wang | Oncology | Best Researcher Award

Dr. Rong Wang, Nanfang Hospital, Southern Medical University, China.

Dr. Rong Wang, a distinguished figure at Nanfang Hospital, Southern Medical University, has built an impressive career that bridges clinical excellence and pioneering research. From her early academic days, she showed a strong commitment to medical science, which translated into impactful professional endeavors in both patient care and research. Her primary focus lies in clinical and translational medicine, where she has made significant contributions through innovative diagnostics, treatment strategies, and interdisciplinary collaboration. Her accolades reflect her dedication, while her influence is evident in the global reach of her work and her role as a mentor and leader in the medical community.

Profile

Orcid

 

🎓 Early Academic Pursuits

Dr. Rong Wang began her academic journey with a strong foundation in medical sciences, reflecting a deep commitment to healthcare from an early stage. Her educational path was marked by excellence, as she pursued rigorous training in clinical medicine and specialized disciplines. Her formative years at esteemed institutions prepared her with a robust understanding of both theoretical and practical dimensions of medical research, setting the stage for a remarkable professional trajectory.

🏥 Professional Endeavors

Currently affiliated with Nanfang Hospital at Southern Medical University, China, Dr. Rong Wang has established herself as a dedicated clinician and researcher. Her work seamlessly integrates patient care with academic inquiry, creating a dynamic synergy between hospital-based practice and medical innovation. Her role at this prestigious institution has enabled her to engage in cutting-edge research, medical education, and multidisciplinary collaborations that enhance both her personal growth and the advancement of the medical field.

🔬 Contributions and Research Focus

Dr. Wang’s research interests are deeply embedded in clinical and translational medicine, particularly focusing on emerging healthcare challenges in China and globally. Her investigations often revolve around innovative diagnostic techniques, treatment protocols, and patient-centered care strategies. With a vision to bridge the gap between laboratory research and bedside application, her contributions have not only enriched scientific literature but also improved therapeutic outcomes.

🏅 Accolades and Recognition

Over the years, Dr. Rong Wang has been the recipient of numerous accolades that reflect her unwavering dedication to medicine and research. Her work has garnered respect from peers and institutions alike, earning her prestigious awards and invitations to speak at national and international conferences. These honors underscore her role as a thought leader and innovator in the field.

🌏 Impact and Influence

Dr. Wang’s influence extends beyond the walls of her hospital. Her research has informed public health policies and contributed to global discourses on health equity and innovation. She actively collaborates with other researchers and healthcare professionals to promote knowledge exchange, medical training, and sustainable healthcare models. Her mentorship has inspired a new generation of researchers and medical practitioners who are carrying forward her legacy of excellence and empathy.

🌟 Legacy and Future Contributions

As she continues to evolve in her career, Dr. Rong Wang remains committed to pioneering research and medical advancement. Her future aspirations include expanding her research on integrative healthcare solutions and influencing healthcare reform through evidence-based policies. Through her persistent efforts, she aims to leave a lasting legacy marked by innovation, compassion, and societal impact.

🧠 Research-Driven Innovation

At the core of Dr. Wang’s professional identity is her relentless pursuit of scientific truth and practical solutions. Her research embodies a spirit of curiosity and a drive to solve complex medical challenges. Whether through publishing in high-impact journals or leading clinical trials, she consistently pushes the boundaries of knowledge, aiming to bring transformative change to patient care and health systems.

publication

  • Title: Establishment and Characterization of a Brain Parenchymal Metastatic Cell Line AlmoR1 Derived From an NSCLC Patient With EGFR‐TKI Resistance
    Authors: Jingyi Wu, Xiangfei Wu, Jing Wang, Guili Feng, Yuhan Wang, Zide Chen, Wei Wang, Rong Wang
    Year: 2025

 

  • Title: Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer
    Authors: Rong Wang, Tadaaki Yamada, Kenji Kita, Hirokazu Taniguchi, Sachiko Arai, Koji Fukuda, Minoru Terashima, Akihiko Ishimura, Akihiro Nishiyama, Azusa Tanimoto, et al.
    Year: 2020

 

🔚 Conclusion

With a future-oriented mindset and an unwavering commitment to advancing healthcare, Dr. Rong Wang stands as a beacon of medical innovation and compassion. Her career is a testament to how scientific research and clinical practice can come together to improve lives and shape the future of medicine. As she continues her journey, her legacy will be defined by her transformative contributions, the people she has inspired, and the advancements she has helped bring to life in the world of healthcare.

Lin Jizhen | Cancer immunotherapy | Best Researcher Award

Prof. Lin Jizhen | Cancer immunotherapy | Best Researcher Award

Prof.  Lin Jizhen, Union Hospital, Fujian Medical University, China.

Dr. Jizhen Lin is a distinguished physician-scientist whose career has been defined by an unwavering dedication to the field of auditory molecular biology. With his foundational medical education from Fujian Medical University and advanced research training in biochemistry and molecular biology at the University of Minnesota, he has seamlessly blended clinical acumen with scientific innovation. His professional roles have evolved from intern and research fellow to Associate Professor and Laboratory Director, reflecting a career rich in mentorship, discovery, and leadership. His research has focused extensively on otitis media and the molecular mechanisms of hearing, contributing valuable insights into the pathophysiology and potential treatments of auditory disorders.

Profile

Scopus

 

📚 Early Academic Pursuits

Dr. Jizhen Lin’s academic journey began with a strong foundation in medicine at Fujian Medical University, Fuzhou, China, where he earned his M.D. in 1982 and an M.S. in Otolaryngology in 1987. His thirst for advanced knowledge and scientific discovery later brought him to the University of Minnesota, Minneapolis, where he immersed himself in the fields of biochemistry and molecular biology, further enriching his expertise and setting the stage for a robust research career in auditory sciences.

🧪 Professional Endeavors

Dr. Lin’s professional path has been marked by consistent dedication and a progressive climb through academic and research positions. His early clinical exposure as an intern at Union Hospital in Fujian laid the groundwork for his subsequent transition into research. Between 1992 and 1995, he served as an International Research Fellow at the Otitis Media Research Center (OMRC), University of Minnesota. He continued to make strides as a Research Scientist and Co-director of the Otopathology-Molecular Biology Laboratory, contributing significantly to auditory molecular biology. His leadership abilities culminated in his appointment as Director of the Auditory Molecular Biology Laboratory, and he has been serving as an Associate Professor in the Department of Otolaryngology at the University of Minnesota Medical School since 2008.

🔬 Contributions and Research Focus

Throughout his career, Dr. Lin has concentrated on unraveling the complexities of auditory molecular biology with a primary focus on otitis media, a prevalent childhood disease. His contributions have been instrumental in bridging clinical otolaryngology with molecular science, employing biochemical tools to investigate the pathogenesis of auditory disorders. His laboratory has played a critical role in advancing understanding of the genetic and cellular mechanisms that underpin hearing loss and middle ear infections, particularly through innovative translational approaches.

🏅 Accolades and Recognition

Dr. Lin’s relentless pursuit of scientific excellence and impactful research has earned him widespread recognition in the field of otolaryngology. His tenure as a Graduate Faculty advisor reflects not only his dedication to mentorship but also the high regard his peers and the academic community have for his expertise. While he may not be adorned with numerous public awards, the esteem in which he is held by colleagues and students alike underscores the quiet yet profound impact of his scholarly work.

🌍 Impact and Influence

The influence of Dr. Lin’s research extends beyond the laboratory, as his findings have contributed meaningfully to clinical practices and therapeutic approaches in otolaryngology. By identifying key molecular targets and pathways involved in auditory disorders, his work continues to shape the development of novel diagnostics and treatments. Furthermore, his role in international research collaborations underscores his commitment to knowledge exchange and global scientific advancement.

🧠 Legacy and Future Contributions

Dr. Lin’s legacy is firmly rooted in the integration of molecular science with clinical otolaryngology, a field he has helped shape through decades of dedicated research and academic mentorship. As a mentor to future scientists and a contributor to critical advancements in auditory health, he remains a cornerstone in the bridge between basic science and patient care. Looking forward, his ongoing work in auditory molecular biology is poised to further uncover the mechanisms of hearing and hearing loss, promising new frontiers in medical intervention and auditory health.

🧬 Lifelong Commitment to Hearing Science

Dr. Lin’s career embodies a lifelong commitment to auditory science, from the clinic to the lab. His seamless blend of clinical knowledge, molecular expertise, and research leadership has fostered a rich legacy in otolaryngology. With ongoing contributions to scientific understanding and future discoveries on the horizon, Dr. Lin continues to inspire a generation of researchers and clinicians dedicated to improving hearing health worldwide.

Publication

  1. Title: Cell-free transcription amplification-based split-type electrochemical sensor using enzyme-linked magnetic microbeads for minimal residual leukemia detection
    Authors: Luying Yu, Jinyuan Chen, Huanjiao Weng, … Xinhua Lin, Guangxian Zhong
    Year: 2025

 

  1. Title: Antibody screening-assisted multichannel nanoplasmonic sensing chip based on SERS for viral screening and variants identification
    Authors: Yi Liu, Huanjiao Weng, Zhiwei Chen, … Shangyuan Feng, Duo Lin
    Year: 2025

 

  1. Title: tRNA methyltransferase DNMT2 promotes hepatocellular carcinoma progression and enhances Bortezomib resistance through inhibiting TNFSF10
    Authors: Junzhong Lai, Linqin Chen, Qiumei Li, … Jizhen Lin, Qi Chen
    Year: 2025

 

  1. Title: Carrimycin ameliorates lipopolysaccharide and cecal ligation and puncture-induced sepsis in mice
    Authors: Junzhong Lai, Jiadi Liang, Kunsen Chen, … Qi Chen, Jizhen Lin
    Year: 2024

 

  1. Title: B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC
    Authors: Bing Chen, Kaifan Zheng, Shubin Fang, … Jizhen Lin, Xinhua Lin
    Year: 2023

 

  1. Title: A drug-delivery depot for epigenetic modulation and enhanced cancer immunotherapy
    Authors: Junzhong Lai, Jiadi Liang, Yong Zhang, … Jizhen Lin, Qi Chen
    Year: 2023

 

  1. Title: Ultrasensitive detection of SARS-CoV-2 antigen using surface-enhanced Raman spectroscopy-based lateral flow immunosensor
    Authors: Shuxia Lai, Yi Liu, Shubin Fang, … Jizhen Lin, Shangyuan Feng
    Year: 2023

 

  1. Title: Retraction Note to: Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner
    Authors: Xiaomin Fu, Xiaoyan Zhu, Fujun Qin, … Qinxian Zhang, Quanli Gao
    Year: Not specified

 

  1. Title: SFPQ Promotes Lung Cancer Malignancy via Regulation of CD44 v6 Expression
    Authors: Libang Yang, Jiangbo Yang, Blake A. Jacobson, … Craig A. Henke, Jizhen Lin
    Year: 2022

 

✅ Conclusion

Dr. Lin’s lifelong commitment to understanding the science of hearing has positioned him as a pioneering figure in otolaryngology. Through decades of research, academic guidance, and clinical collaboration, he has built a legacy rooted in translational science and patient-centered innovation. His work continues to influence both basic research and clinical practice, promising a future where auditory health is better understood and more effectively managed. As a scientist, mentor, and innovator, Dr. Lin stands as an enduring contributor to the advancement of hearing science.